Cancer Therapy News and Research

RSS

Breakthrough fluorine discovery may impact how pharmaceutical companies develop new drugs

A groundbreaking discovery by chemists at The University of Texas at San Antonio will have a significant impact on how pharmaceutical companies develop new drug treatments.

6 Sep 2018

Scientists identify 'Achilles heel' of anaplastic large-cell lymphomas

Anaplastic large-cell lymphomas are rare cancers of the white blood cells. New research from the international ERIA consortium, led by scientists in Vienna, has now shown that the same signaling pathway is essential to the growth of cancer cells in various forms of ALCL: TYK2 (tyrosine kinase 2, an important component of the immune system) prevents apoptotic cell death by increasing the production of Mcl1, a special type of protein belonging to the BCL2 family.

3 Sep 2018

Groundbreaking CURATE.AI platform halts progression of advanced cancer

A translational research team led by the National University of Singapore has harnessed CURATE.AI, a powerful artificial intelligence platform, to successfully treat a patient with advanced cancer, completely halting disease progression.

31 Aug 2018

NUS researchers harness AI platform to treat patient with advanced cancer

31 Aug 2018

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

Two Texas-based nonprofits, Candlelighters of El Paso and the Light and Salt Association, have been named the recipients of the American Society for Radiation Oncology2018 Survivor Circle grants. Each organization will receive a $10,000 grant to aid their cancer support programs and will be recognized at an award ceremony on October 23 during ASTRO's 60th Annual Meeting in San Antonio.

30 Aug 2018

For nursing home patients, breast cancer surgery may do more harm than good

Surgery is a mainstay of breast cancer treatment, offering most women a good chance of cure.

29 Aug 2018

Cherwell confirms support for conference addressing key challenges in aseptic manufacturing of ATMPs

Cherwell Laboratories, supplier of environmental monitoring and process validation products, has confirmed its continued support for the Pharmaceutical & Healthcare Sciences Society - UCL Q3P Annual Conference 2018.

29 Aug 2018

Developing a Flexible X-ray Detector

In this interview, Dr. Imalka Jayawardena from the University of Surrey talks about the development of a flexible X-ray detector that will help clinicians analyze X-ray images and deliver targeted doses of radiation when using X-rays as a treatment.

29 Aug 2018

New study suggests chemotherapy may cause early menopause in women with lung cancer

A new study suggests chemotherapy may cause acute amenorrhea leading to early menopause in women with lung cancer.

29 Aug 2018

Study explores whether chemotherapy affects older woman's ability to function

Older women are at higher risk for developing breast cancer than younger women are--almost half of all breast cancer cases, and most breast cancer deaths, occur in women who are 65 or older. Despite this, we know very little about how breast cancer and its treatments affect older women.

29 Aug 2018

A non-canonical approach may improve radiation treatment for cancer

Although the success or failure of radiation therapy for cancer has long been associated with the intrinsic radio-resistance or radio-sensitivity of tumor cells, a new approach is demonstrating that radiation can take credit for an additional benefit - causing highly effective secondary immune responses that can enhance anti-tumor immunity.

28 Aug 2018

Experts to discuss concepts, methods of gender medicine and their impact on oncology

Gender-based approaches to studying and treating disease have remained largely unexplored in medical oncology, despite the field's growing interest in precision medicine and accumulating evidence that sex is a major factor in disease risk and response to treatment.

28 Aug 2018

New combination treatment could help some people with advanced melanoma

A UCLA-led study has found that a treatment that uses a bacteria-like agent in combination with an immunotherapy drug could help some people with advanced melanoma, an aggressive form of skin cancer, live longer.

28 Aug 2018

Patients with blood pressure must start treatment with two drugs as a single pill

A single pill with two drugs could transform blood pressure treatment, according to the 2018 European Society of Cardiology and European Society of Hypertension Guidelines on arterial hypertension published online today in European Heart Journal, and on the ESC website.

25 Aug 2018

Researchers develop new system for effective cancer diagnosis and treatment

A research group consisting of scientists from NUST MISIS, the Technical University of Munich, Helmholtz Zentrum München, the University of Duisburg-Essen, and the University of Oldenburg has developed a system that allows doctors to both improve the accuracy of diagnosing malignant cells and to provide additional opportunities for cancer treatment.

24 Aug 2018

HU researchers develop new biological drug that may cure acute myeloid leukemia

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefited from new treatments, there has been no encouraging news for most leukemia patients for the past 40 years. Until now.

24 Aug 2018

Researchers take major step in eliminating cancer without harming healthy tissue

A major advance towards targeting cancer without harming healthy tissue has been discovered by University of Bristol researchers.

24 Aug 2018

'Plastic antibodies' effectively target and eliminate tumor cells

A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Economic burden of breast cancer can continue long after diagnosis

The financial fallout from breast cancer can last years after diagnosis, particularly for those with lymphedema, a common side effect from treatment, causing cumulative and cascading economic consequences for survivors, their families, and society, a study led by Johns Hopkins Bloomberg School of Public Health researchers suggests.

22 Aug 2018

Cancer Therapy News and Research

Breakthrough fluorine discovery may impact how pharmaceutical companies develop new drugs

Scientists identify 'Achilles heel' of anaplastic large-cell lymphomas

Groundbreaking CURATE.AI platform halts progression of advanced cancer

NUS researchers harness AI platform to treat patient with advanced cancer

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

For nursing home patients, breast cancer surgery may do more harm than good

Cherwell confirms support for conference addressing key challenges in aseptic manufacturing of ATMPs

Developing a Flexible X-ray Detector

New study suggests chemotherapy may cause early menopause in women with lung cancer

Study explores whether chemotherapy affects older woman's ability to function

A non-canonical approach may improve radiation treatment for cancer

Experts to discuss concepts, methods of gender medicine and their impact on oncology

New combination treatment could help some people with advanced melanoma

Patients with blood pressure must start treatment with two drugs as a single pill

Researchers develop new system for effective cancer diagnosis and treatment

HU researchers develop new biological drug that may cure acute myeloid leukemia

Researchers take major step in eliminating cancer without harming healthy tissue

'Plastic antibodies' effectively target and eliminate tumor cells

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Economic burden of breast cancer can continue long after diagnosis

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News